Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2016 2
2018 2
2019 1
2020 1
2021 1
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

7 results

Results by year

Filters applied: . Clear all
Page 1
Histone macroH2A1.2 promotes metabolic health and leanness by inhibiting adipogenesis.
Pazienza V, Panebianco C, Rappa F, Memoli D, Borghesan M, Cannito S, Oji A, Mazza G, Tamburrino D, Fusai G, Barone R, Bolasco G, Villarroya F, Villarroya J, Hatsuzawa K, Cappello F, Tarallo R, Nakanishi T, Vinciguerra M. Pazienza V, et al. Among authors: cannito s. Epigenetics Chromatin. 2016 Oct 25;9:45. doi: 10.1186/s13072-016-0098-9. eCollection 2016. Epigenetics Chromatin. 2016. PMID: 27800025 Free PMC article.
Epigenetic Immune Remodeling of Mesothelioma Cells: A New Strategy to Improve the Efficacy of Immunotherapy.
Lofiego MF, Cannito S, Fazio C, Piazzini F, Cutaia O, Solmonese L, Marzani F, Chiarucci C, Di Giacomo AM, Calabrò L, Coral S, Maio M, Covre A, On Behalf Of The EPigenetic Immune-Oncology Consortium Airc Epica Investigators. Lofiego MF, et al. Among authors: cannito s. Epigenomes. 2021 Dec 14;5(4):27. doi: 10.3390/epigenomes5040027. Epigenomes. 2021. PMID: 34968251 Free PMC article.
Immunomodulatory Properties of DNA Hypomethylating Agents: Selecting the Optimal Epigenetic Partner for Cancer Immunotherapy.
Fazio C, Covre A, Cutaia O, Lofiego MF, Tunici P, Chiarucci C, Cannito S, Giacobini G, Lowder JN, Ferraldeschi R, Taverna P, Di Giacomo AM, Coral S, Maio M. Fazio C, et al. Among authors: cannito s. Front Pharmacol. 2018 Dec 7;9:1443. doi: 10.3389/fphar.2018.01443. eCollection 2018. Front Pharmacol. 2018. PMID: 30581389 Free PMC article.
Fifteenth Meeting of the Network Italiano per la Bioterapia dei Tumori (NIBIT) on Cancer Bio-Immunotherapy, Siena, Italy, October 5-7, 2017.
Maio M, Lofiego MF, Fazio C, Cannito S, Chiarucci C, Giacobini G, Valente M, Tunici P, Covre A, Russo V. Maio M, et al. Among authors: cannito s. Cancer Immunol Immunother. 2019 Jan;68(1):151-158. doi: 10.1007/s00262-018-2222-0. Epub 2018 Aug 9. Cancer Immunol Immunother. 2019. PMID: 30094463 Free PMC article. No abstract available.
De Novo p.Asp3368Gly Variant of Dystrophin Gene Associated with X-Linked Dilated Cardiomyopathy and Skeletal Myopathy: Clinical Features and In Silico Analysis.
d'Apolito M, Ranaldi A, Santoro F, Cannito S, Gravina M, Santacroce R, Ragnatela I, Margaglione A, D'Andrea G, Casavecchia G, Brunetti ND, Margaglione M. d'Apolito M, et al. Among authors: cannito s. Int J Mol Sci. 2024 Feb 28;25(5):2787. doi: 10.3390/ijms25052787. Int J Mol Sci. 2024. PMID: 38474032 Free PMC article.
Efficacy and epigenetic interactions of novel DNA hypomethylating agent guadecitabine (SGI-110) in preclinical models of hepatocellular carcinoma.
Jueliger S, Lyons J, Cannito S, Pata I, Pata P, Shkolnaya M, Lo Re O, Peyrou M, Villarroya F, Pazienza V, Rappa F, Cappello F, Azab M, Taverna P, Vinciguerra M. Jueliger S, et al. Among authors: cannito s. Epigenetics. 2016 Oct 2;11(10):709-720. doi: 10.1080/15592294.2016.1214781. Epub 2016 Sep 20. Epigenetics. 2016. PMID: 27646854 Free PMC article.